Parenteral Nutrition Market Overview (2023-2030)

Market Size and Growth:

• 2023 Market Value: USD 7.53 billion
• Projected 2030 Market Value: USD 11.19 billion
• CAGR (2024-2030): 5.82%

Definition and Usage: Parenteral nutrition (PN), or intravenous feeding, supplies nutrients directly into the bloodstream, bypassing the digestive system. It’s used for patients who cannot absorb nutrients through the digestive tract due to illness, surgery, or other medical conditions.

To know about the Research Methodology :- Request Free Sample Report

Key Drivers:

1. Increasing Prevalence of Chronic Diseases: Conditions like cancer, gastrointestinal disorders, and neurological diseases drive the demand for PN.
2. Rising Geriatric Population: Older adults are more prone to chronic diseases and malnutrition, increasing the need for PN.
3. Technological Advancements: Innovations in the formulation and delivery of PN solutions enhance market growth.
4. Home Healthcare Demand: More patients are receiving treatment at home, driving demand for PN products.
5. COVID-19 Impact: The pandemic has increased the emphasis on nutrition therapy and hospitalizations, boosting the PN market.

Key Trends and Opportunities:

• Personalized Medicine: Tailoring PN solutions to individual needs is a growing trend.
• Aseptic Compounding Facilities: Investments in modern compounding facilities increase production capacity and improve supply resilience.
• Product Launches and Strategic Initiatives: Companies are focusing on mergers, acquisitions, and collaborations to gain a competitive edge.

Recent Developments:

• Protara Therapeutics (April 2024): Aligned with the FDA for IV Choline Chloride, potentially becoming the first FDA-approved IV choline therapy for PN patients.
• Baxter Healthcare (July 2022): Invested over $15 million in an aseptic compounding facility in Dublin to enhance domestic production and support at-home patient treatment.

To know about the Research Methodology :- Request Free Sample Report

Market Segmentation

By Nutrient Type:

1. Carbohydrates
2. Parenteral Lipid Emulsion: High demand due to essential fatty acids.
3. Single Dose Amino Acid Solution: Expected to grow due to the increasing prevalence of chronic diseases and demand for personalized medicine.
4. Trace Elements
5. Vitamins & Minerals: Significant growth driven by awareness of malnutrition.

By Patient Type:

• Adult
• Pediatrics

By End-User:

• Hospitals
• Clinics
• Homecare
• Other End-Users

Regional Insights

North America:

• Leader in the Market: High healthcare expenditure, awareness regarding malnutrition, and favorable reimbursement policies.
• Key Player: Protara Therapeutics' alignment with the FDA on IV Choline Chloride.

Europe:

• Major Contributors: Germany, France, UK
• Notable Investment: Bayer's 130 million EUR production facility in Berlin.

Asia Pacific:

• Fastest Growing Region: Significant contributions from China, India, Japan.
• Key Investment: Baxter Healthcare's aseptic compounding facility in Dublin.

Competitive Landscape

Major Players:

• North America: Baxter, Pfizer (Hospira), Allergan
• Europe: B. Braun Melsungen, Fresenius Kabi, ViforPharma, Grifols, Actavis
• Asia Pacific: Otsuka Pharmaceutical, Sichuan Kelun, Aculife Healthcare, Anhui Medipharm, Amanta Healthcare

To know about the Research Methodology :- Request Free Sample Report

FAQs

1. What are the growth drivers for the Parenteral Nutrition Market?

   • Increasing prevalence of chronic diseases and malnutrition.

2. What is the major opportunity for market growth?

   • Rising demand for personalized medicine.

3. Which country is expected to lead the market?

   • Europe is expected to lead the Parenteral Nutrition Market during the forecast period.

4. What is the projected market size and growth rate?

   • The market is expected to grow from USD 7.53 billion in 2023 to USD 11.19 billion by 2030 at a CAGR of 5.82%.

5. What segments are covered in the market report?

   • Nutrient Type, Patient Type, End-user, and Region.

This detailed analysis showcases the dynamic and evolving nature of the Parenteral Nutrition Market, driven by technological advancements, an aging population, and increased awareness about malnutrition and chronic diseases.